Artal Group S.A. Ac Immune Sa Transaction History

Artal Group S.A.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	BUY	$4.78 - $9.06 $73,851 - $139,977	15,450 Added 1.57%	1,000,000 $4.88 Million
Q2 2020 Aug 14, 2020	SELL	$6.57 - $8.3 $101,506 - $128,235	-15,450 Reduced 1.55%	984,550 $6.63 Million
Q1 2019 May 10, 2019	BUY	$3.65 - $11.68 $912,500 - $2.92 Million	250,000 Added 33.33%	1,000,000 $5.05 Million
Q3 2018 Nov 09, 2018	BUY	$7.88 - $16.45 $1.18 Million - $2.47 Million	150,000 Added 25.0%	750,000 $6 Million
Q1 2018 May 10, 2018	BUY	$10.34 - $13.78 $1.03 Million - $1.38 Million	100,000 Added 20.0%	600,000 $6.2 Million
Q3 2017 Nov 08, 2017	BUY	$7.06 - $11.2 $3.53 Million - $5.6 Million	500,000	500,000 $5.59 Million

27.9M

150K

12.4K

Ticker ACIU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,413,504
Market Cap $218M
Description
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

Stay updated on Artal Group S.A. with notifications on news.